
FDA & Government News


April 24, 2025
Combination Immunotherapy Approved for Unresectable or Metastatic Hepatocellular Carcinoma
The ASCO Post


February 21, 2024
FDA Approves Biweekly Teclistamab Dosing Regimen for Patients With Multiple Myeloma
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.


January 17, 2025
FDA Approves Datopotamab Deruxtecan-dlnk for Advanced HR-Positive, HER2-Negative Breast Cancer
The ASCO Post


Advertisement
Recommendations
Advertisement